Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Mizuho cut Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) price target from $140 to $132. Mizuho…